Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-30
2007-01-30
Hui, San-ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S338000, C514S370000
Reexamination Certificate
active
10496809
ABSTRACT:
The present invention relates to a method of treating anti-bacterial infections which method comprises the separate, simultaneous or sequential administration to a patient in need thereof, of an effective amount of gemifloxacin or a salt thereof and a β-lactam antibiotic.
REFERENCES:
patent: WO 98/42705 (1998-10-01), None
Ronald Arky, The Physicians' Desk Reference, 1997, 51 Edition, pp. 930, 1070-1073, and 1259-1261, for example.
Wise R. and Andrews J.M., “The in-Vitro Activity and Tentative Breakpoint of Gemifloxacin, a new Fluoroquinolone”, In: J. Antimivrob. Chemother., Nov. 1999, 44(5): pp. 679-688.
Zhang L. et al., “Fluoroquinolone Susceptibilities of Efflux-Mediated Multidrug-ResistiantPseudomonas aeruginosa. Stenotrophomonas maltophiliaandBurkholderia cepacia.” In: J. Antimicrob. Chemother., Oct. 2001, 48(4) : pp. 549-552.
Hoban D.J. et al., “A Comparative in Vitro Surveillance Study of Gemifloxacin Activities Against 2,632 RecentStreptococcus pneumoniaeIsolates from Across Europe, North America, and South America. The Gemifloxacin Surveillance Study Research Group.” In: Antimicrob. Agents Chemother., Nov. 2000., 44(11) : pp. 3008-3011.
Hoban D.J. et al., “Comparative in Vitro Activity of Gemifloxacin, Ciprofloxacin, Levofloxacin and Ofloxacin in a North American Surveillance Study.” In: diagn. Microbiol. Infect. Dis., May-Jun. 2001, 40(102) : pp. 51-57.
Visalli M.A. et al., “Determination of Activities of Levofloxacin, Alone and Combined with Gentamicin,Ceftazdime, Cefpirome, and Meropenem, Against 124 Strains ofPseudomonas aeruginosaby Checkerboard and Time-Kill Methodology.” In: Antimicrob. Agents Chemother., Apr. 1998., 42(4) : pp. 953-955.
Aubert G. et al., “In Vitro Effect of New Fluoroquinolones and Betalactamines Combinations Against Enterococci.” In: Pathol. Biol., Dec. 1999. 39(10) : pp. 1006-1008.
Kim Mu-Yong
McCloskey Lynn
Niconovich Nancy
Paek Kyong-Sook
Rittenhouse Stephen
Hui San-ming
LG Life Sciences Ltd.
LandOfFree
Method of treating bacterial infections using gemifloxacin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating bacterial infections using gemifloxacin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating bacterial infections using gemifloxacin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3811122